Navidea Biopharmaceuticals, Inc. (NAVB)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.98 Million | -10.21 Million | -8.17 Million | -9.35 Million | 4.27 Million | 59.08 Million |
| Net Income | -15.17 Million | -11.73 Million | -10.72 Million | -10.94 Million | -16.11 Million | 74.94 Million |
| Depreciation & Amortization | 95.81 Thousand | 76.95 Thousand | 70.39 Thousand | 144.51 Thousand | 150.38 Thousand | 254.58 Thousand |
| Deferred income taxes | - | -267.26 Thousand | 5654.00 | 60.1 Thousand | 5.29 Million | 4.64 Million |
| Stock-based compensation | 301.35 Thousand | 471.26 Thousand | 230.52 Thousand | 232.05 Thousand | 306.69 Thousand | 394.2 Thousand |
| Change in working capital | 5.11 Million | 947.16 Thousand | 1.83 Million | 1.12 Million | 13.83 Million | -25.18 Million |
| Other non-cash items | 675.46 Thousand | 284.66 Thousand | 401.74 Thousand | 34.38 Thousand | 806.27 Thousand | 4.03 Million |
| Investing Cash Flow | -390.34 Thousand | -329.42 Thousand | -412.82 Thousand | 770.42 Thousand | 953.8 Thousand | -1.83 Million |
| Investments in PPE | -390.34 Thousand | -329.42 Thousand | -413.87 Thousand | -56.7 Thousand | -46.19 Thousand | -33.69 Thousand |
| Acquisitions | - | - | 1042.00 | 27.12 Thousand | 46.19 Thousand | 39.22 Million |
| Investment purchases | - | - | - | - | -600 Thousand | -2.2 Million |
| Sales/Maturities of investments | - | - | - | 800 Thousand | 1.6 Million | 400 Thousand |
| Other Investing Activities | -327.26 Thousand | -304.2 Thousand | 1042.00 | 27.12 Thousand | -46.19 Thousand | -39.22 Million |
| Financing Cash Flow | 7.14 Million | 12.1 Million | 10.2 Million | 6.15 Million | -4.54 Million | -55.99 Million |
| Debt repayment | -518.08 Thousand | -491.77 Thousand | -368.55 Thousand | -359.06 Thousand | -395.57 Thousand | -59.75 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -17.36 Thousand | - | - | - | - |
| Common Stock Issuance | 30.00 | 4346.00 | 4.44 Million | 7.08 Million | 3 Million | 72.41 Thousand |
| Other Financing Activities | 7.65 Million | 12.63 Million | 6.13 Million | -572.27 Thousand | -7.15 Million | 3.68 Million |
| Accounts receivables | 92.36 Thousand | 655.31 Thousand | 1.94 Million | -68.24 Thousand | 12.92 Million | 1.88 Billion |
| Accounts payables | 701.22 Thousand | 259.6 Thousand | 49.64 Thousand | 687.35 Thousand | -430.32 Thousand | -6.01 Million |
| Inventory | -459.19 Thousand | 18.64 Thousand | -169.79 Thousand | 68.24 Thousand | 1.35 Million | 1.47 Million |
| Other working capital | 4.78 Million | 13.6 Thousand | 13.6 Thousand | 435.07 Thousand | -15.03 Thousand | -1.9 Billion |
| Cash at beginning of period | 4.23 Million | 2.67 Million | 1.04 Million | 3.47 Million | 2.79 Million | 1.53 Million |
| Cash at end of period | 1.99 Million | 4.23 Million | 2.67 Million | 1.04 Million | 3.47 Million | 2.79 Million |
| Capital Expenditure | -390.34 Thousand | -329.42 Thousand | -413.87 Thousand | -56.7 Thousand | -46.19 Thousand | -33.69 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.23 Million | 1.56 Million | 1.62 Million | -2.42 Million | 680.87 Thousand | 1.25 Million |
| Free Cash Flow | -9.37 Million | -10.54 Million | -8.58 Million | -9.41 Million | 4.22 Million | 59.04 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.68 Million | 6.03 Million | -1.47 Million | -3.48 Million | -15.17 Million | -5.7 Million |
| Depreciation & Amortization | 27.02 Thousand | 27.13 Thousand | 27.55 Thousand | 26.46 Thousand | 95.81 Thousand | 24.7 Thousand |
| Deferred income taxes | -750 Thousand | 185.05 Thousand | - | - | - | - |
| Stock-based compensation | 10.34 Thousand | -33.84 Thousand | 19.66 Thousand | 34.89 Thousand | 301.35 Thousand | 41.05 Thousand |
| Change in working capital | -35.05 Thousand | -1.63 Million | 779.45 Thousand | 834.35 Thousand | 5.11 Million | 3.51 Million |
| Other non-cash items | 179.06 Thousand | 115.7 Thousand | -1.07 Million | 153.78 Thousand | 675.46 Thousand | 114.77 Thousand |
| Investing Cash Flow | -524.65 Thousand | -65 Thousand | -39.4 Thousand | -72.03 Thousand | -390.34 Thousand | -78.92 Thousand |
| Investments in PPE | -16.52 Thousand | -65.33 Thousand | -39.4 Thousand | -72.03 Thousand | -390.34 Thousand | -78.92 Thousand |
| Acquisitions | - | 336.00 | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 750 Thousand | - | - | - | - | - |
| Other Investing Activities | -508.13 Thousand | 336.00 | -24.34 Thousand | -72.03 Thousand | -327.26 Thousand | -64.49 Thousand |
| Financing Cash Flow | -188.57 Thousand | 1.48 Million | -200.53 Thousand | -99.76 Thousand | 7.14 Million | 6.2 Million |
| Debt repayment | -138.57 Thousand | -504.5 Thousand | -200.53 Thousand | -64.66 Thousand | -518.08 Thousand | -1 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -49.99 Thousand | 1.68 Million | - | 30.00 | 30.00 | - |
| Other Financing Activities | -49.99 Thousand | 1.98 Million | -200.53 Thousand | -35.13 Thousand | 7.65 Million | -963.27 Thousand |
| Accounts receivables | 13.84 Thousand | -13.66 Thousand | -30.41 Thousand | 92.36 Thousand | 92.36 Thousand | -125.12 Thousand |
| Accounts payables | 62.85 Thousand | -1.16 Million | 1.04 Million | 384.01 Thousand | 701.22 Thousand | -688.13 Thousand |
| Inventory | - | -110.00 | -33.29 Thousand | -283.53 Thousand | -459.19 Thousand | -11.14 Thousand |
| Other working capital | -97.9 Thousand | -458.29 Thousand | -984.88 Thousand | 641.5 Thousand | 4.78 Million | 744.71 Thousand |
| Cash at beginning of period | 6.14 Million | 33.79 Thousand | 1.99 Million | 4.6 Million | 4.23 Million | 328.01 Thousand |
| Cash at end of period | 3.86 Million | 6.14 Million | 33.79 Thousand | 1.99 Million | 1.99 Million | 4.6 Million |
| Capital Expenditure | -16.52 Thousand | -65.33 Thousand | -39.4 Thousand | -72.03 Thousand | -390.34 Thousand | -78.92 Thousand |
| Effect of forex changes on cash | 8.68 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -2.27 Million | 6.11 Million | -1.96 Million | -2.6 Million | -2.23 Million | 4.27 Million |
| Free Cash Flow | -10.26 Million | 4.62 Million | -1.76 Million | -2.5 Million | -9.37 Million | -1.93 Million |
KAMDHENU
CAE
603388
7826
OCGN
SPARC